Related Experiment Videos
[Hyperdynamic syndrome in myocardial infarct]
Insights
Hyperdynamic syndrome in myocardial infarction patients indicates a heightened stress response. This condition elevates complication risks and mortality rates.
Area of Science:
- Cardiology
- Physiology
Background:
- Myocardial infarction (MI) is a leading cause of death worldwide.
- Understanding the physiological responses post-MI is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the characteristics and implications of hyperdynamic syndrome in patients with myocardial infarction.
- To identify biomarkers and metabolic factors associated with the development of hyperdynamic syndrome post-MI.
Main Methods:
- Investigated 172 patients with myocardial infarction.
- Categorized patients into hyperdynamic (n=72) and normodynamic (control, n=100) groups based on cardiac performance.
- Assessed blood catecholamine, 11-OCS levels, and energy metabolism.
Main Results:
- Hyperdynamic syndrome was observed in 72 of 172 MI patients within the initial days.
- Elevated catecholamine and 11-OCS levels, along with enhanced energy metabolism, were associated with hyperdynamic syndrome.
- This syndrome reflects a more pronounced stress response.
Conclusions:
- Hyperdynamic syndrome in MI patients is linked to increased stress markers and metabolic changes.
- The presence of hyperdynamic syndrome is associated with higher complication rates, prolonged disease duration, and increased risk of fatal cardiorrhexis.
Abstract:
A total of 172 patients with myocardial infarction were investigated. The hyperdynamic syndrome was revealed in 72 patients within the first days of the disease, as manifested in increased cardiac performance, while 100 patients, whose hemodynamics were of normodynamic type, made up the control group. The hyperdynamic syndrome was shown to develop in the presence of elevated blood catecholamine and 11-OCS content and enhanced energy metabolism, reflecting a more pronounced response to stress. The development of the hyperdynamic syndrome increases the rates of complications associated with myocardial infarction, prolongs the duration of the disease and builds up the risk of fatal outcome due to cardiorrhexis.